HC News

• Dr. Jiménez Suárez, especialista en psiquiatría en HC Marbella
• HC Marbella a la vanguardia de la salud ocular con la inauguración de su nuevo centro oftalmológico
• HC Marbella, primer hospital andaluz en obtener la prestigiosa marca Q de Calidad en turismo sanitario
• Vitamin D, just a trend?
• Estudio de la composición corporal para un diagnóstico preciso de la obesidad
• If I had known I was going to live this long, I would have taken better care of myself
• Herpes Zóster
• Helicobacter pylori infection
• The Mediterranean Diet in the prevention and management of cancer
• Dr Cristina Nuño Rodríguez is a specialist in Radiation Oncology at HC Cancer Center
• More news

Update in prostate cancer: benefits of prostate specific antigen (PSA) and its screening

What are the benefits of PSA?

It is shown that PSA screening reduces deaths from prostate cancer.

 

At what age should I do it?

If there is a family history we recommend from the 40, otherwise it is recommended after 45-50 years.

The age that we do not recommend PSA is not defined, but for very elderly patients with associated major illness this does not seem to bring benefits.

 

Are there new biomarkers of prostate cancer alternative to PSA?

They are currently developing new markers for the detection of prostate cancer. For now, the PSA and its molecular formulas remain the reference, although new markers appear promising.

Example of bookmarks to decide when biopsy: pro-PSA, kallikrein K4, PCA3 gene.

There are also monograms or models to calculate the risk of prostate cancer; they can assist decision-making between the doctor and the patient, and to agree with the patient with the risks and benefits of PSA screening.

 
 
Dr. José Manuel Fernández Montero
Director of the Urology Unit of HC Marbella
 
 

June 11th World Day of Prostate Cancer

www.cancerprostata.org

 

 

 

 

June 11, 2015

 

 

 

Read other news